WORLD'S LARGEST MARKET RESEARCH RESOURCE — 1,519,265 REPORTS

 
 
• SEARCH FOR A REPORT

Viewing report

Search
Enter keywords, a title or a report id number below.
Advanced

• ORDER BY FAX

Order By Fax

• SELECT SITE CURRENCY

Select a currency for use throughout the site



  • Electronic (PDF) Information Icon
  • Site License Information Icon
  • Enterprisewide Information Icon
Live Chat Live Help Software for Website

CoMentis, Inc. - Product Pipeline Review - H2 2011

Global Markets Direct, December 2011, Pages: 46

CoMentis, Inc. – Product Pipeline Review – H2 2011

Summary

Global Market Direct’s pharmaceuticals report, “CoMentis, Inc. - Product Pipeline Review - H2 2011” provides data on the CoMentis, Inc.’s research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.

This report is built using data and information sourced from Global Markets Direct’s proprietary databases, CoMentis, Inc.’s corporate website, SEC filings, investor presentations and featured press releases, both from CoMentis, Inc. and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- CoMentis, Inc. - Brief CoMentis, Inc. overview including business description, key information and facts, and its locations and subsidiaries.
- Review of current pipeline of CoMentis, Inc. human therapeutic division.
- Overview of pipeline therapeutics across various therapy areas.
- Coverage of current pipe



List of Tables
List of Figures
CoMentis, Inc. Snapshot
CoMentis, Inc. Overview
Key Information
Key Facts
CoMentis, Inc. – Research and Development Overview
Key Therapeutic Areas
CoMentis, Inc. – Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products – Monotherapy
CoMentis, Inc. – Pipeline Products Glance
CoMentis, Inc. Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
CoMentis, Inc. – Early Stage Pipeline Products
Pre-Clinical Products/Combination Treatment Modalities
CoMentis, Inc. – Drug Profiles
ATG002
Product Description
Mechanism of Action
R&D Progress
CTS-21166
Product Description
Mechanism of Action
R&D Progress
GTS-21
Product Description
Mechanism of Action
R&D Progress
Next Generation Beta Secretase Inhibitor
Product Description
Mechanism of Action
R&D Progress
CoMentis

Customers who bought this item also bought